KETOCONAZOLE IN THE TREATMENT OF PITYRIASIS VERSICOLOR - INTERNATIONAL REVIEW OF CLINICAL-TRIALS

被引：7
|
作者：
GOODLESS, DR
RAMOSCARO, FA
FLOWERS, FP
机构：
[1] UNIV FLORIDA,COLL MED,J HILLIS MILLER HLTH CTR,DIV DERMATOL,BOX J-277,GAINESVILLE,FL 32610
[2] UNIV FLORIDA,COLL MED,DEPT MED,GAINESVILLE,FL 32610
[3] GAINESVILLE VET AFFAIRS MED CTR,DERMATOL & CUTANEOUS SURG SECT,GAINESVILLE,FL
来源：
DICP-THE ANNALS OF PHARMACOTHERAPY | 1991年 / 25卷 / 04期
关键词：
D O I：
10.1177/106002809102500411
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Multiple open and double-blind studies have confirmed the efficacy of ketoconazole in the treatment of pityriasis versicolor. Single-dose (400 mg) or short-course (200 mg/d for five days) therapy may be highly effective for selected patients with pityriasis versicolor. Toxicity seems to be minimal at this dosage.
引用
收藏
页码：395 / 398
页数：4
相关论文
共 50 条
12345